| Submission date: |
|
| Entrepreneur's Country of Origin: |
Spain
|
| Round: |
Vigésimoprimera Ronda de Inversores Santander (Cantabria), España
|
| Country of Project Execution: |
Spain
|
| Investment: |
1.500.000
|
| Currency: |
EUR
|
Aptadel develops RNA aptamer technology for cancer treatment. Our pipeline is based on an aptamer platform whose dual mechanism of action, antimetastatic effect and intracellular transport of different therapeutic agents, is adaptable to a wide range of oncological indications. The company's main product is focused on childhood cancer.
